期刊文献+

不同剂量阿托伐他汀对急性冠脉综合征患者炎症及血小板和纤溶活性的影响 被引量:17

Effects of Different Dosage of Atorvastatin on Inflammation,Platelet Activity and Fibrinolytic Activity in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的观察冠脉综合征(ACS)患者应用不同剂量(10mg、20mg、40mg)阿托伐他汀治疗前后外周血中总胆固醇(TC)、超敏C-反应蛋白(hs-CRP)、白介素-6(IL-6)、血小板血栓烷B2(TXB2)、血小板α-颗粒膜蛋白-140(GMP-140)、纤溶酶原激活物抑制剂(PAI-1)水平、组织型纤溶酶原激活剂(t-PA)活性及肝功能的变化,探讨大剂量阿托伐他汀治疗ACS的疗效及安全性。方法ACS患者65例,在拜阿司匹林、氯吡格雷等基础治疗后随机分为3组,分别给予阿托伐他汀10mg/d、20mg/d、40mg/d,睡前服用。入院第1d、第14d抽取空腹静脉血16ml。测定hs-CRP、IL-6、TXB2、GMP-140、t-PA、PAI-1及TC、天门冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、肌酸激酶(CK)含量。采用SPSS13.0统计软件对检测结果的组间及治疗前后进行比较。结果3组患者TC、hs-CRP、IL-6、TXB2、GMP-140、PAI-1治疗后均有下降、t-PA活性上升;治疗后上述各指标3组间比较亦有差异;而3组治疗前后CK、ALT、AST组间比较无差异,治疗均后无显著上升。结论大剂量阿托伐他汀治疗ACS的疗效优于常规剂量,同时未增加药物的副作用。 Objective To investigate the effect and safety of large dosage of Atorvastatin in treatment of acute coronary syndrome (ACS) through the change of total cholesterol (TC), high sensitivity reactive protein (hs -CRP) , iterlieukin -6 (IL - 6) , Thromboxane B2 ( TXB2 ) , α - granule membrane protein - 140 ( GMP - 140 ) , plasminogen activator inhibitor - 1 (PAI - 1 ) level and tissue type plasminogen activator ( t - PA) activity in peripheral blood ; as well as the hepatic function of patients with ACS before and after treatment with different dosage of Atorvastatin. Methods Totally 65 cases of ACS patients were randomly divided as tree groups which were respectively given 10mg/d, 20mg/d, 40mg/d Atorvastatin before sleeping besides routine treatments of aspirin and clopidogrel. On the first day and 14th day of admission, 16 ml venous blood was taken for measuring hs- CRP, IL-6, TX B2, GMP- 140, t- PA, PAI- 1, TC and aspartate aminotransferase (AST) , alanine amiotransferase (ALT) , creatine kinase (CK). SPSS 13.0 statistical software was used to compare the data before and after treatment. Results TC, hs-CRP, IL-6, TX B2, GMP-140, PAI-1 decreased significantly in all three groups, whilet-PAactivation increased remarkably. And after the treatment, there were significant differences among three groups on these items. But no visible statistic differences were found in CK, AST, and ALT among three groups. Conclusion Large dosage of Atorvastatin is better than routine dosage on treatment for ACS and of good safety.
出处 《中国全科医学》 CAS CSCD 2007年第13期1060-1062,共3页 Chinese General Practice
关键词 冠心病 急性冠脉综合征 炎症反应 血小板活性 纤溶活性 阿托伐他汀 Coronary heart disease Acute coronary syndrome Inflammation response Platelet activity Fibrinolytic activity Atorvastatin
  • 相关文献

参考文献14

  • 1Busws C,Hemandez-Presa MA,Ortego M,et al.HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atheroselerosis[J].J Am Coil Cardiol,1998,32:2057-2064.
  • 2Aikawa M,Rabkin E,Sugiyama S,et al.An HMG-CoA reductase inhibitor,cerivastatin,suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro[J].Circulation,2001,103:276-283.
  • 3Bourcier T,Libby P.HMG-CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells[J].Arterioscler Thromb Vasc Biol,2000,20:556-562.
  • 4Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.A report of American college of cardiology/American heart association task force on p ractice guidelines[J].J Am Coil Cardiol,2000,36:970.
  • 5郭伟民,肖传实.冠状动脉钙化及其程度与冠心病危险因素关系的研究[J].中国全科医学,2006,9(14):1150-1152. 被引量:16
  • 6O'Malley T,Ludlam C A,Riemermsa R A,et al.Early increase in levels of soluble intercellular adhesion molecule-1(sICAM-1),potential risk factor for the acute coronary syndromes[J].Eur Heart J,2001,22:1226-1234.
  • 7孙艳凌,张丛辉,蔡久英.炎症与急性冠脉综合征[J].中国误诊学杂志,2003,3(6):837-839. 被引量:6
  • 8吴国新,阮长耿.血小板颗粒膜蛋白研究进展[J].中华血液学杂志,1994,15(3):162-164. 被引量:231
  • 9吴国新,李建勇.血小板表面及血浆内α—颗粒膜蛋白的放射免疫测量[J].中华血液学杂志,1992,13(2):99-100. 被引量:104
  • 10黄久菊,杨丽伟.老年脑梗塞患者血纤溶活性与血小板活化的关系[J].中国误诊学杂志,2003,3(5):739-739. 被引量:3

二级参考文献57

  • 1郭红,陈洪波.不稳定心绞痛血清炎性标志物测定的临床意义[J].中国误诊学杂志,2004,4(3):404-405. 被引量:18
  • 2王娟,赵虹.不同剂量辛伐他汀对急性冠状动脉综合征患者高敏C反应蛋白的影响[J].河北医药,2005,27(10):741-742. 被引量:4
  • 3Spyek JP,Chung CL.Mayor SEH, et al. Resolutin of cutaneous leishmaniasis:Interleukin-12 initiates a protective T helper typel immune response. J ExpMed, 1993,177 (6) : 1797-1802.
  • 4Biasucci LM,Colizzi C,et al. Role of inflammation in the pathogenesis on unstable coronary diseases[J]. Scand .I Clin Lab Invest, 1999.59(snppl230) : 12-22.
  • 5Prediman K,Shah MD. Plaque disruption and throm-bosis : Potential role of inflammation and infection. Cardiol Rev, 2000, 8 (3) :32-39.
  • 6Ferreios ER,Boissonnet CP, Pizarro R,et al. Independent prognostic value of elevated Creactive protein in unstable angina. Circulation, 1999,100(19) : 1958-1963.
  • 7Kinlay S,Selwyn AP,Libby P,et al. Inflammation.the endothelium,and the acute coronary syndromes. J Cardiovase Pharmacol,1998.32 (Suppl 3) : 62-66.
  • 8Shah PK, Falk E, Badimon JJ, et al. Human monocyte derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plague. potential role of matrix degrading metalloproteinases and implications for plaque rupture [J]. Circulation, 1995, 9
  • 9Ross R. Atherosclerosis-an inflammatory disease[J].N Eng J Med,1999,340(2) :115-126 .
  • 10Biasucci LM, Colizzi C, Rizzello V, et al. Role of inflammation in the pathogenesis of unstable coronary artery diseases[J].Scand J Clin Lab Invest,1999, 59(Suppl230):12-22.

共引文献356

同被引文献171

引证文献17

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部